ICON - Investors - ICON plc - Investor Relations
OVERVIEW
INVESTOR.ICONPLC.COM RANKINGS
Date Range
Date Range
Date Range
LINKS TO WEB SITE
Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. 2 - 5 April, 2018.
Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. 2 - 5 April, 2018.
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full service solution.
Global network of CAP accredited laboratories. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Global experience in all Phases of oncology drug development. Experience in cardiovascular trials supported by a global team of experts. ICON has conducted diabetes trials in all global regions.
WHAT DOES INVESTOR.ICONPLC.COM LOOK LIKE?
INVESTOR.ICONPLC.COM HOST
WEBSITE IMAGE
PAGE TITLE
ICON - Investors - ICON plc - Investor RelationsDESCRIPTION
Site and Patient Recruitment. Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Rare and Orphan Diseases. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. Cardiovascular and Metabolic Disorders. 2 - 5 April, 2018.CONTENT
This web site has the following on the web site, "Lower-cost transactional solutions with strategic resourcing and innovative technologies." We noticed that the web site also said " Integrated services that cover planning, management, execution and analysis." It also said " Insight on strategies and execution for long-term value to maximise success. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. 2 - 5 April, 2018." The header had ICON as the highest ranking optimized keyword.SEEK SIMILAR WEB PAGES
Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe. Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market. Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015. Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics. Q2 2015 Illumina, Inc.
Vision, Mission and Values. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. Avi Pelossof Appointed President and CEO of Immucor.
What is an ADC? What is an ADC? And in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. More information about the Company can be found at www. ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Society of Gynecologic Oncology Annual Meeting. There are no items to display.
InContact Reports Second Quarter 2015 Financial Results. InContact CEO Paul Jarman and CFO Greg Ayers to Present at the Oppenheimer 18th Annual Technology, Internet and Communications Conference. InContact Sets Second Quarter 2015 Conference Call. International Business Process Outsourcer Expands Existing inContact Solution with Workforce Management in the Cloud.
Q2 2015 Incyte Corporation Earnings Conference Call. Q2 2015 Incyte Corporation Earnings Conference Call. Click here to add this event to your calendar. Incyte to Report Second Quarter Financial Results on August 4.